Form 8-K - Current report:
SEC Accession No. 0001493152-24-049790
Filing Date
2024-12-12
Accepted
2024-12-12 16:15:33
Documents
14
Period of Report
2024-12-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40935
  Complete submission text file 0001493152-24-049790.txt   265064

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bfrg-20241207.xsd EX-101.SCH 3718
3 XBRL DEFINITION FILE bfrg-20241207_def.xml EX-101.DEF 29945
4 XBRL LABEL FILE bfrg-20241207_lab.xml EX-101.LAB 36511
5 XBRL PRESENTATION FILE bfrg-20241207_pre.xml EX-101.PRE 26968
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5681
Mailing Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878
Business Address 325 ELLINGTON BLVD. UNIT 317 GAITHERSBURG MD 20878 3013672055
BullFrog AI Holdings, Inc. (Filer) CIK: 0001829247 (see all company filings)

EIN.: 844786155 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41600 | Film No.: 241545007
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)